Caspase-7 belongs to the trio (caspase-3, -6, -7) of executioner cysteinyl aspartate-specific proteases and can also act as a pro-inflammatory factor. Caspase-7 is involved in apoptosis in a number of tissues.^[@bib1],\ [@bib2]^ Among these, the cleaved (activated) form of caspase-7 has been detected in the primary enamel knot of the first molar, a site where apoptosis takes place. However, caspase-7 was also detected in non-apoptotic areas of differentiating odontoblasts and ameloblasts.^[@bib3]^ This observation was further emphasised by the fact that caspase-7 knock-out (Casp7−/−) mice showed a significant decrease in the amount of enamel deposition in mouse incisors.^[@bib4]^ Furthermore, non-apoptotic effects of other caspases have also been reported in other tissues, including a role in proliferation of T cells, in cell-cycle regulation, differentiation of keratinocytes, formation of erythrocytes or platelets, lens development, and skeletal muscle maturation.^[@bib5]^

Along with its presence in teeth, the activated form of caspase-7 was observed in the forming alveolar processes developing from the mandibular bone of mouse embryos.^[@bib3]^ In the present work, we investigated the role of caspase-7 in two types of bone; intramembranous bones (mandibular and alveolar) and endochondral bones (front and hind limbs). In the former type, osteoblasts directly differentiate from the condensed mesenchyme, while in the latter a cartilaginous anlage initially forms that is later replaced by bone.^[@bib6]^ Osteogenesis consists of several successive steps and is regulated by complex molecular interactions, involving products of genes such as bone morphogenetic proteins -- *Bmps*,^[@bib7]^ fibroblast growth factors -- *Fgfs*,^[@bib8]^ hedgehog genes,^[@bib9]^ vascular endothelial growth factor -- *Vegf*,^[@bib10],\ [@bib11]^ transforming growth factor -- *Tgfβ* pathway,^[@bib12]^ and transcription factors such as Msh homeobox -- *Msx1*,^[@bib13]^ SRY-box -- *Sox9*,^[@bib14]^ and runt-related transcription factor -- *Runx2*.^[@bib15]^ In this study, the distribution of caspase-7 was investigated during bone development and the effect of caspase-7 deficiency on bone formation was assessed. The findings uncover novel roles of caspase-7 in bone formation, and reveal differences in action dependent on the developmental history of the bone.

Results
=======

Activation of caspase-7 during the development of intramembranous and endochondral bones
----------------------------------------------------------------------------------------

### Intramembranous ossification (mandibular and alveolar bones)

At embryonic day (ED) 12.5, condensed mesenchymal cells lateral to Meckel\'s cartilage were in evidence at the site of the developing jaw bones, and both the activated form of caspase-7 and osteocalcin, a marker of osteogenesis, were absent (data not shown). The activated form of caspase-7 appeared first at ED13.5 ([Figures 1e and f](#fig1){ref-type="fig"}) coincident with osteocalcin expression ([Figures 1n and o](#fig1){ref-type="fig"}), as the bone matrix of the developing mandible started to become apparent ([Figure 1a](#fig1){ref-type="fig"}). During further embryonic development (ED15.5 and ED17.5), localisation of the activated form of caspase-7 remained similar ([Figures 1g--k](#fig1){ref-type="fig"}). Meckel\'s cartilage was negative at ED17.5 ([Figure 1j](#fig1){ref-type="fig"}), which was similar also at earlier stages (data not shown). The activation of caspase-7 was localised particularly to the cytoplasm and positively correlated with osteocalcin expression ([Figures 1p--s](#fig1){ref-type="fig"}). As development progressed (ED15.5 and ED17.5), the size of the mandibular bone increased ([Figures 1b and c](#fig1){ref-type="fig"}). Caspase-7 was apparent also at postnatal day (P) 5 in the alveolar bone ([Figures 1l and m](#fig1){ref-type="fig"}) and still synchronised with osteocalcin expression ([Figures 1t and u](#fig1){ref-type="fig"}). The precursor cells of the alveolar bone originate from the dental follicle.^[@bib16]^ During early postnatal development, the alveolar bone forms and becomes a part of the mandible ([Figure 1d](#fig1){ref-type="fig"}). While osteocalcin was observed in the cytoplasm of bone cells and also in bone matrix, the activated form of caspase-7 was observed predominantly in the cytoplasm at all stages studied.

### Endochondral ossification (bones of front limbs)

At ED13.5, neither the activated form of caspase-7 nor osteocalcin was detected in the cartilaginous ulna and radius of the developing forelimb, agreeing with the fact that no bone tissue was visible at this stage (data not shown). When bone formation started, at ED14.5 ([Figure 2a](#fig2){ref-type="fig"}), the activated form of caspase-7 was detected in a thin cellular layer (periosteum) adjacent to the surface of hypertrophic chondrocytes ([Figures 2e and f](#fig2){ref-type="fig"}). Osteocalcin was detected at the same time and spatially co-distributed with caspase-7 ([Figures 2m and n](#fig2){ref-type="fig"}). Later, at ED15.5 ([Figures 2g and h](#fig2){ref-type="fig"}), caspase-7 was visualised in the enlarging zone of ossification, at ED 17.5 ([Figures 2i and j](#fig2){ref-type="fig"}) caspase-7 was localised in the region of the bone collar. A similar pattern was observed for osteocalcin ([Figures 2o--r](#fig2){ref-type="fig"}). During this period (ED15.5--ED17.5), the size of the bone tissue progressively increased ([Figure 2b](#fig2){ref-type="fig"}). From ED17.5, proliferating, pre-hyperthrophic, and hyperthrophic chondrocytes as well as primary bone were clearly detectable ([Figure 2c](#fig2){ref-type="fig"}). Finally, at P6, caspase-7 ([Figures 2k and l](#fig2){ref-type="fig"}) and osteocalcin ([Figures 2s and t](#fig2){ref-type="fig"}) were detected in forming primary bone ([Figure 2d](#fig2){ref-type="fig"}). The proliferating and hypertrophic zones of the cartilage were caspase-7 negative at all stages examined. As observed in the alveolar bone, the activated form of caspase-7 was detected particularly in the cytoplasm at all stages.

Correlation between caspase-7-positive cells and apoptosis in the alveolar bone
-------------------------------------------------------------------------------

Apoptosis is associated with bone remodelling during postnatal stages of tooth and jaw development.^[@bib17]^ At P0, apoptosis was observed in the alveolar bone ([Figure 3b](#fig3){ref-type="fig"}), where activated caspase-7 was also present ([Figure 3a](#fig3){ref-type="fig"}). Not all caspase-7-positive cells, however, were associated with the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)-positive regions. In some TUNEL-positive cells, the nucleus showed positive staining for active caspase-7 ([Figures 3a and b](#fig3){ref-type="fig"}), indicating that apoptosis was working through this caspase, which was also documented in our previous study on primary enamel knot.^[@bib3]^ However, in those cells with active caspase-7 in the cytoplasm no TUNEL staining was observed, indicating a dual function for caspase-7 depending on its subcellular localisation ([Figures 3a and b](#fig3){ref-type="fig"}).

Influence of caspase-7 deficiency on intramembranous and endochondral bone formation in adult mice -- morphological aspects
---------------------------------------------------------------------------------------------------------------------------

### Alveolar bone

The length of molar row and cusps pattern were not altered in caspase-7-deficient mice ([Figure 4d](#fig4){ref-type="fig"}) compared with wild types ([Figure 4a](#fig4){ref-type="fig"}), as observed from 3D reconstructions of micro-computed tomography (microCT) images. Sagittal and frontal sections in the molar region of the jaw did not reveal any striking difference in the alveolar bone organization in Casp7−/− mice ([Figures 4e and f](#fig4){ref-type="fig"}) compared with wild type ([Figures 4b and c](#fig4){ref-type="fig"}).

### Femur

3D reconstruction of the distal femur showed different organisation of trabeculae in Casp7−/− mice, as observed in longitudinal ([Figure 5f](#fig5){ref-type="fig"}) or transversal ([Figure 5e](#fig5){ref-type="fig"}) sections, when compared with wild-type mice ([Figures 5b and a](#fig5){ref-type="fig"}). Changes in endosteal ([Figure 5g](#fig5){ref-type="fig"}) and periosteal ([Figure 5h](#fig5){ref-type="fig"}) surfaces were also recognised in Casp7−/− mice, where a smoothed surface was observed, in contrast to the greater porosity observed in the cortex in wild-type mice ([Figures 5c and d](#fig5){ref-type="fig"}).

Influence of caspase-7 deficiency on intramembranous and endochondral bone formation of adult mice -- quantitative analysis
---------------------------------------------------------------------------------------------------------------------------

### Alveolar bone (intramembranous)

MicroCT analysis of the alveolar bone of the mandible in Casp7−/− mice showed a statistically significant (*P*=0.024) decrease ([Figure 6b](#fig6){ref-type="fig"}) in bone mineral content (BMC). The bone mineral density (BMD), however, was not decreased ([Figure 6c](#fig6){ref-type="fig"}). Interestingly, the bone volume in Casp7−/− mice appeared to be significantly (*P*=0.024) decreased ([Figure 6a](#fig6){ref-type="fig"}) which was not clearly apparent from the morphological assessment. These results point to an overall decrease in alveolar bone volume. The decrease in alveolar bone volume was estimated to be around 24%. Therefore, reduction in one dimension would appear to be \<3%, which is difficult to recognise by morphological assessment. Similar trends were obtained by examination of the whole mandible (data not shown).

Femur (endochondral)
--------------------

In femoral trabecular bone of Casp7−/− mice, microCT analysis revealed a statistically significant (*P*=0.009) decrease in BMC ([Figure 6f](#fig6){ref-type="fig"}) and a significant (*P*=0.009) decrease in BMD ([Figure 6g](#fig6){ref-type="fig"}). Analysis of the cortex also showed a significant (*P*=0.011) decrease in BMC ([Figure 6d](#fig6){ref-type="fig"}) and a significant (*P*=0.009) decrease in BMD ([Figure 6h](#fig6){ref-type="fig"}). In contrast to the alveolar bone, the volume of bone was not reduced ([Figure 6e](#fig6){ref-type="fig"}) and the bone volume/tissue volume (BV/TV) ratio ([Figure 6i](#fig6){ref-type="fig"}) was unaffected (*P*=0.886). Trabecular separation and thickness were not impacted by caspase-7 deficiency (data not shown).

Caspase-7 *versus* caspase-3 in bone
------------------------------------

To assess whether any other caspases compensated for the loss of caspase-7, we analysed the activation of the effector caspase, caspase-3. Immunohistochemical analysis of mandibular bone at stage ED 15.5 ([Figures 7a and b](#fig7){ref-type="fig"}) did not show any apparent increase in activation of caspase-3 in the caspase-7-deficient mandibular bone ([Figures 7c and d](#fig7){ref-type="fig"}) compared with wild type ([Figures 7e and f](#fig7){ref-type="fig"}). In keeping with this finding, the distribution of caspase-7 did not always overlap with that of caspase-3 (see [Figures 7o and p](#fig7){ref-type="fig"}). In addition, we observed no decrease in the distribution of apoptotic cells in caspase-7-deficient mice ([Figures 7g--j](#fig7){ref-type="fig"}), nor in the expression of osteocalcin ([Figures 7k--n](#fig7){ref-type="fig"}). At P0, activation of caspase-3 and -7 was found in a similar number of osteoclasts (activated caspase-3 was detected in 54% of osteoclasts and activated caspase-7 was detected in 50% of osteoclasts). However, activation of both caspases was different in osteoblasts (activated caspase-3 was detected in 28% of osteoblasts and activated caspase-7 was detected in 71% of osteoblasts). Overall, our data indicate that caspase-3 probably does not compensate for the loss of caspase-7 as a general mechanism during bone formation.

Impact of caspase-7 deficiency on osteogenic gene expression
------------------------------------------------------------

Gene expression changes in isolated mandibular bone were assessed using a PCR array comprised of 84 genes involved in osteogenesis ([Figures 8a--c](#fig8){ref-type="fig"}). Caspase-7-deficient mandibular bone showed a statistically significant decrease in the expression of *Msx1* (fold change: −2.17; *P*=0.0058) and *Smad1* (fold change: −2.2; *P*=0.0147) in early development (ED15.5). In contrast, an increase in liver/bone/kidney form of alkaline phosphatase -- *Alp* (fold change: 2.14; *P*=0.0438) was found in the Casp7−/− mandibular bone. Moreover, a decreasing trend but not a statistically significant drop was observed in other important genes implicated in ossification such as ameloblastin -- *Ambn* (fold change: −2.99), bone morphogenetic protein receptor -- *Bmpr1a* (fold change: −2.18), dentin matrix protein -- *Dmp1* (fold change: −4.64), *Fgf2* (fold change: −2.29), fibroblast growth factor receptor -- *Fgf2r* (fold change: −2.02), matrix metalloproteinase -- *Mmp8* (fold change: −3.21).

Discussion
==========

Caspases have been described as taking part in both apoptotic and non-apoptotic processes.^[@bib18],\ [@bib5]^ Previous investigations have shown that caspases have a role in cell differentiation either involving incomplete apoptosis (e.g., cells of the lens) or by completely non-apoptotic pathways (macrophages and skeletal muscles).^[@bib19]^ With reference to non-apoptotic functions, caspase-7 was proposed to be involved in hard tissue formation,^[@bib4]^ as immunostaining for caspase-7 showed its presence in developing mandibular bone.^[@bib3]^ This observation led us to investigate the localisation of caspase-7 in cells of the intramembranous bones of the mandible from ED12.5 to P5 and the bone phenotype in adult (P28) Casp7−/− mice.

In the present work, the activated form of caspase-7 was detected in the mandibular bone from early stages of development (ED13.5). At this stage, the developing mandibular bone can be identified as emerging from a mass of condensed mesenchymal cells.^[@bib20]^ Activated caspase-7 was present at the same time as osteocalcin, used as a marker for osteogenesis. This pattern for the activated form of caspase-7 in mandibular bone, and later also in alveolar bone, persisted at postnatal stages. Caspase-7-positive cells predominated in non-apoptotic regions. This activation pattern therefore indicates that caspase-7 might have a role in both early bone formation and later bone development.

Analysis of Casp7−/− mice showed that the BMD was comparable to that of wild-type animals. However, the BMC and volume of the alveolar bone were significantly decreased, when compared with wild types suggesting an overall decrease in alveolar bone volume. Similar trends were obtained also by examination of the mandible. Thus, data from immunohistochemistry and microCT analysis pointed to the role of caspase-7 in the formation of the alveolar bone.

The bones of the lower jaw form by intramembranous ossification, as a comparison we therefore also investigated long bones, which form by endochondral ossification. The activated form of caspase-7 was detected in long bones throughout embryonic and early postnatal development. The first time point of detection was ED14.5, when the centres of ossification initiate in the mouse front limbs.^[@bib21]^ The timing of initiation of active caspase-7 in mandibular and long bone reflects the distinct timing of ossification in both models. A similar delay of 1 day between the jaw primordia (ED11.5) and femur (ED12.5) has also been reported for the expression of Core binding factor alpha -- *Cbfa1 (Runx2)*, a marker of osteoblast differentiation.^[@bib21]^

MicroCT analysis showed differences in bone organisation, as the trabeculae system was decreased and changes in endosteal and periosteal surfaces were apparent in Casp7−/− mice. In contrast, microCT analysis showed that parameters such as trabecular thickness and separation, bone volume, or BV/TV ratio were not altered in Casp7−/− mice. However, a significant decrease in BMC and BMD was detected in both cortical and trabecular bones.

The effect of caspase-7 deficiency, as observed by microCT, was quite distinct in intramembranous and endochondral bones. One explanation for this may relate to the different characteristics of both types of ossification.^[@bib22]^ Developmental differences in intramembranous and endochondral ossification have been reported when comparing gene expression patterns of periostin,^[@bib23]^ *Bmps,*^[@bib24]^ or variation in the vascularisation.^[@bib25]^ Furthermore, deficiency of *Bmp2/6* resulted in reduced endochondral bone formation, but had no impact on intramembranous bone.^[@bib26]^ Therefore, the expression or/and function of distinct genes in both models may differ, which may also be the case for caspase-7.

During mineralisation of the long bone, caspase-7 as a protease may be involved in specific transcription factor cleavage,^[@bib27]^ which might induce a specific cell lineage programme in bone cells. Caspase-7 does not, however, seem to be a critical factor for early stages of bone formation. Our studies show decreased bone density in the femur and decreased volume of alveolus in adult Casp7−/− mice.

Structural similarities^[@bib28]^ and tissue-specific functional redundancies between caspase-7 and caspase-3 have previously been reported.^[@bib1],\ [@bib3],\ [@bib29]^ In contrast to the relatively mild effect of caspase-7 deficiency in the femur, caspase-3-deficient mice showed a reduction in trabecular thickness and decreased BV/TV ratio.^[@bib30]^ In Casp7−/− mandibular bone, an increase in the activation of caspase-3 was not observed compared with wild-type mice. Moreover, the expression of activated caspase-3 and caspase-7 did not overlap completely in wild-type tissue, with activated caspase-7 being detected in a larger number of osteoblasts compared with caspase-3. We therefore conclude that the relatively mild bone phenotype we describe in the caspase-7 knock-outs was not due to compensation by caspase-3. Previous studies also delineated partial differences in the protease activities,^[@bib31]^ in substrate specificity and localisation of the two activated caspases as described in murine liver after Fas stimulation.^[@bib32],\ [@bib33]^ From these observations, caspase-3 appeared more effective in the cleavage of molecules with low molecular weight,^[@bib31],\ [@bib34]^ and was also more promiscuous.^[@bib32]^ Therefore, caspase-7 in the femur may have a much more specific effect on bone mineralisation. The importance of caspases in bone formation is also supported by studies where overexpression of *Bcl-2* was shown to result in the inhibition of osteoblast differentiation.^[@bib35]^

To try to better understand the effect of caspase-7, osteogenic signalling was investigated in Casp7−/− and wild-type mice. PCR array analysis of genes involved in osteogenesis was performed on total RNA obtained from the mandibular bone (including also developing alveolar processes) at ED15.5. At this early stage of mandibular bone formation in caspase-7-deficient mice, several genes involved in osteogenesis (*Bmpr1a*, *Ambn*, *Dmp1*, *Fgf2*, *Fgfr2*, and *Mmp8*) showed a decreasing trend, although this was not statistically significant. All these genes are involved in different periods of bone formation.^[@bib7],\ [@bib8],\ [@bib36],\ [@bib37],\ [@bib38]^

Moreover, there was a statistically significant decrease in *Msx1* and *Smad1*, both of which are involved in bone formation.^[@bib12],\ [@bib39]^ *Smad1* is one of the key players in BMP pathway and induces bone formation.^[@bib40]^ *In vitro* studies point to a role for *Smad1* in osteoblasts terminal differentiation^[@bib41]^ and inhibition of *Bmp6*, which acts upstream of *Smad1*, results in the inhibition of osteogenesis in alveolar bone.^[@bib42]^ Moreover, a decrease in BMP signalling has been suggested to result in a decreased bone volume in young adult mice.^[@bib43]^

Therefore, the reduced levels of *Smad1* and *Msx1* products during embryonic development support the significant decrease in intramembranous bones volume that we observed in adult Casp7−/− mice.

Despite a significant decrease in the volume of the alveolar bone in adult Casp7−/− mice, PCR arrays revealed a significant increase in *Alp* mRNA in Casp7−/− mice at ED15.5. ALP is present at the surface of osteoblasts and its activity is required for production of high phosphate concentration for bone mineralization.^[@bib44]^ Previous investigations described a positive correlation between *Alp* mRNA levels and ALP activity although contradictory results also exist.^[@bib45],\ [@bib46],\ [@bib47]^ Notably, higher levels of ALP activity were associated with lower levels of *Alp* mRNA.^[@bib48]^ ALP activity cannot thus be determined from *Alp* mRNA synthesis. There may be several post-transcriptional/post-translational modifications involved in production of active ALP by osteoblast.

In conclusion, this study of Casp7−/− mice shows for the first time that the presence of caspase-7 influences intramembranous and endochondral bone development in specific ways. Previous studies have shown that executive caspases are cleaved/activated in the cytoplasm.^[@bib33],\ [@bib49],\ [@bib50]^ Afterwards, they are translocated to the nucleus to perform their function by cleavage of poly(ADP-ribose) polymerase -- PARP or other proteins such as chromosomal passenger complex members.^[@bib51],\ [@bib52],\ [@bib53]^ In the present study focusing on bone, caspase-7 was not detected in the nucleus. Moreover, the mandibular bone in the caspase-7 knock-out did not show any apparent decrease in the distribution of apoptotic cells. These observations further support the non-apoptotic functions described above. A similar situation with a different context has already been reported for *β*-catenin.^[@bib54]^ Our study highlights the fact that the nuclear or cytoplasmic localisation of caspase-7 may impact on its mode of function (cell death, inflammation, growth regulation, or differentiation), and it will be important to investigate this further to try and understand what determines subcellular localisation.

Materials and Methods
=====================

Samples
-------

Mouse heads and front limbs at ED 12.5, 13.5, 14.5, 15.5, 17.5 and P 5, 6 were used to investigate localisation of activated form of caspase-7 in bone formation. Collected samples were fixed in 4% buffered paraformaldehyde for 24 h. For immunohistochemistry procedure dehydrated in ethanol gradient, treated with xylene, and embedded in paraffin. Postnatal mouse heads or front limbs at embryonic stages ED17.5 were decalcified in buffered EDTA before dehydration. Frontal sections of heads and longitudinal sections of front limbs were prepared. Mice were killed according to the experimental protocol 37/2011G approved by Department of Physiology, UVP, Brno, Czech Republic.

Casp7−/− mice that had been backcrossed over at least 10 generations were provided by Professor P Vandenabeele^[@bib55]^ and samples processed as for wild-type animals. Embryonic (ED15.5) and postnatal (P28) stages of caspase-7-deficient mice and their littermates were involved in the study.

Immunohistochemistry
--------------------

Slides were treated with xylene to remove the paraffin, rehydrated through an ethanol series and pre-treated in citrate buffer (pH=6.0) 15 min/98°C. Endogenous peroxidase activity was eliminated by 3% hydrogen peroxide in PBS (5 min/room temperature). The primary antibodies (9664-Cleaved caspase-3 and 9491S-Cleaved caspase-7, Cell Signaling, Danvers, MA, USA; ab93876-Osteocalcin, Abcam, Cambridge, UK) were diluted 1 : 50 (caspase-7) and 1 : 100 (Osteocalcin) and applied overnight/4 °C, peroxidase-conjugated streptavidin-biotin system (Vectastain, Burlingame, CA, USA) and chromogen substrate diaminobenzidine (DAB, K3466, Dako, Carpinteria, CA, USA) reactions were used to visualise positive cells as brown. Slides were counterstained by haematoxylin to clearly distinguish the cell nuclei. Negative control was performed by omitting the primary antibody, specificity of anti-caspase antibodies was verified using caspase-7-deficient tissues. Counting of caspase-3- and caspase-7-positive cells was carried out under magnification × 1000 (for osteoclast, *n*=50; for osteoblasts, *n*=500).

TUNEL assay
-----------

Slides were treated with xylene, rehydrated in ethanol series, and endogenous peroxidase was blocked by 3% hydrogen peroxide in PBS (5 min/room temperature). Samples were pre-treated with proteinase K 20 mg/ml (15 min/room temperature). The reaction mixture (TUNEL, S7100, Millipore, Billerica, MA, USA) was prepared as follows: 3 *μ*l TdT enzyme, 42 *μ*l distilled water, 105 *μ*l reaction buffer, which was incubated for 45 min at 37 °C. An anti-digoxigenin-peroxidase reaction was performed for 30 min/room temperature. Positive cells were finally visualised by the chromogenic substrate diaminobenzidine (DAB, K3468, Dako). Samples were counterstained by haematoxylin.

MicroCT analysis
----------------

Specimens for microCT were scanned using a GE Locus SPmicroCT scanner (GE Healthcare, London, ON, Canada). The specimens were immobilised using cotton gauze and scanned to produce 1 *μ*m voxel size volumes, using a X-ray tube voltage of 80 kVp and a tube current of 80 *μ*A. An aluminium filter (0.05 mm) was used to adjust the energy distribution of the X-ray source. CT attenuation values were calibrated to hydroxyapatite standards. In femur, bone parameters were assessed in the distal part, the region of interest was restricted under the growth plate extending 2 mm proximally. Two bone compartments (cortex and trabeculae) were separated by manual contouring that was outlined adjacent to endocortical boundary. Alveolar bone was analysed as one domain. Regions of interest were reconstructed and analysis of BMC, BMD, BV, and TV was carried out using the Microview 2.2 software package (GE Healthcare).

The decrease in alveolar bone was calculated from the average values (four samples in both groups) of bone volume analysed by microCT. When compared with wild type (determined as 100% volume), the alveolar bone volume of caspase-7-deficient mice was calculated as 76%. Therefore, the decrease was 24%.

3D images were post processed by the VGStudio MAX 2.2 software (VGStudio MAX, Heidelberg, Germany). Statistical analysis was evaluated by Sigma Plot 11.2 (Systat software GmbH, Erkrath, Germany). *T*-test (*P*\<0.05) was determined for assessment of statistical significance in all cases except BV/TV ratio, where Mann--Whitney test was used. Eight adult specimens were analysed in both alveolar bone and femur (four wild types and four Casp7−/−).

RNA isolation
-------------

Before the processing, mice heads were stored in RNA Later, washed in PBS and fixed in 4% paraformaldehyde up to 24 h. Samples were dehydrated in ethanol gradient, treated with xylene, embedded in paraffin and 4 *μ*m slices were prepared. Samples embedded in paraffin were arranged during 1 week. Mandibular bones were accurately cut off each slice under stereoscopic conditions as documented in [Figures 7a and b](#fig7){ref-type="fig"}. Selected parts of tissue were used for RNA isolation by the RNeasy FFPE Kit (Qiagen, Valencia, CA, USA). All procedures were carried out in RNAse-free conditions.

PCR array
---------

Expression of gene panel connected with osteogenesis was assessed by PCR array. Examination of 84 genes was performed in the assay. Total mRNA was transcribed into cDNA and used for the investigation by Mouse Osteogenenic PCR array (PAMM-026A-24, SA Biosciences, Frederick, MD, USA). Data were statistically evaluated by PCR array Data Analysis V4 (SA Biosciences). Statistical significance was determined using a *t*-test (*P*\<0.05). The threshold of fold change was established as −2/2 fold-change, that means decrease/increase of 100% in investigated sample. Six embryonic specimens (ED15.5) were analysed (3 wt, 3 Casp7−/−).
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![Localisation of activated caspase-7 and osteocalcin in mandibular and alveolar bones at embryonic and postnatal stages. Morphology of mandible visualised by haematoxylin-eosin staining at ED13.5 (**a**), ED15.5 (**b**), ED17.5 (**c**), and P5 (**d**). Localisation of activated (cleaved) caspase-7 in cells of mandibular bone at ED13.5 (**e** and **f**), ED15.5 (**g** and **h**), ED17.5 (**i**--**k**), and alveolar bone at P5 (**l** and **m**). Expression of osteocalcin in cells of mandibular bone at ED13.5 (**n** and **o**), ED15.5 (**p** and **q**), ED17.5 (**r** and **s**), and alveolar bone at P5 (**t** and **u**). Arrows point to the positive cells (brown); alv (alveolar bone), C7 (caspase-7), I (incisor), M1 (first molar), mand (mandibular bone), mec (Meckel\'s cartilage), and OS (osteocalcin). Scale bar=100 *μ*m in figures: **a**, **b**, **c**, **d**, **e**, **g**, **i**, **j**, **l**, **n**, **p**, **r**, **t**; scale bar=50 *μ*m in figures: **f**, **h**, **k**, **m**, **o**, **q**, **s**, **u**](cddis2014330f1){#fig1}

![Localisation of activated caspase-7 and osteocalcin in long bones of front limb (ulna, radius) at embryonic and postnatal stages. Morphology of bones of front limb visualised by haematoxylin-eosin and Alcian blue staining at ED14.5 (**a**), ED15.5 (**b**), ED17.5 (**c**), and P6 (**d**). Localisation of activated (cleaved) caspase-7 in areas of ossification at ED14.5 (**e** and **f**), ED15.5 (**g** and **h**), ED17.5 (**i** and **j**), and P6 (**k** and **l**). Expression of osteocalcin in areas of ossification at ED14.5 (**m** and **n**), ED15.5 (**o** and **p**), ED17.5 (**q** and **r**), and P6 (**s** and **t**). Arrows point to the positive cells (brown); C7 (caspase-7), hc (hypertrophic chondrocytes), OS (osteocalcin), pb (primary bone), pc (proliferating chondrocytes), and pm (perichondrium). Scale bar=100 *μ*m](cddis2014330f2){#fig2}

![Co-localisation of caspase-7-positive cells and apoptosis in alveolar bone at P0. Localisation of activated (cleaved) caspase-7 in cells of alveolar bone (**a**), apoptotic cells visualised by TUNEL assay (**b**). White arrows point to the positive cells (brown), red arrows point to apoptotic cell (**b**) and cell with nuclear localisation of caspase-7 (**a**); C7 (caspase-7). Scale bar=50 *μ*m](cddis2014330f3){#fig3}

![Morphological evaluation of alveolar bone in adult Casp7−/− and wild-type mice. Row of three mice molar in wild type and (**a**) and Casp7−/− (**d**), sagittal section of mandible in wild type (**b**) and Casp7−/− (**e**), frontal section of the middle part of the first molar region in wild type and (**c**) and Casp7−/− (**f**); wt, (wild type)](cddis2014330f4){#fig4}

![Morphological evaluation of distal femur in adult Casp7−/−and wild-type mice. Transversal section of femur in wild type (**a**) and Casp7−/−(**e**), longitudinal section of wild type (**b**) and Casp7−/−(**f**), endosteal surface of wild type (**c**) and Casp7−/−(**g**), periosteal surface of wild type (**d**) and Casp7−/−(**h**); wt, wild type](cddis2014330f5){#fig5}

![MicroCT analysis of bone parameters of alveolar bone and femur in Casp7−/−and wild-type mice. Bone volume of alveolar bone (**a**) and femur (**e**), BMC of alveolar bone (**b**) and femur (**f**), BMD of alveolar bone (**c**) and femur (**g**), BMC of femoral cortex (**d**), BMD of femoral cortex (**h**), and BV/TV ratio of femur (**i**); wt, (wild type)](cddis2014330f6){#fig6}

![Activation of caspase-3 (**c**--**f**), distribution of apoptotic cells (**g**--**j**), and expression of osteocalcin (**k**--**n**) in Casp7−/− (**a**, **c**, **d**, **g**, **h**, **k**, **l**) *versus* wild-type mice (**b**, **e**, **f**, **i**, **j**, **m**, **n**) at ED15.5, and spatial correlation of caspase-3 (**o**) and caspase-7 (**p**) in wild-type mice at P0. Morphology of mandible visualised by haematoxylin-eosin staining in Casp7−/− (**a**) and wild-type mice (**b**). White arrows point to the positive cells (brown), yellow arrows point to cells with activation of caspase-3 and caspase-7, red arrows point to cells where solely caspase-7 is activated; C3 (caspase-3), C7 (caspase-7), man (mandibular bone), mec (Meckel\'s cartilage), OS (osteocalcin). Scale bar=100 *μ*m](cddis2014330f7){#fig7}

![Changes of osteogenic gene expression in Casp7−/− and documentation of mandibular bone separation for PCR array analysis. Frontal section of murine head (ED15.5), haematoxylin-eosin (**a**), mandibular bone cut off the surroundings under stereoscopic conditions, haematoxylin-eosin (**b**). Examination of osteogenic gene expression in Casp7−/− by PCR array (**c**), significant changes are marked by asterisk. Scale bar=100 *μ*m](cddis2014330f8){#fig8}
